Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20111
20121
20132
20141
20151
20161
20177
20184
20192
20203
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche4
AbbVie2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Amgen1
Arcus Biosciences, Inc.1
AstraZeneca1
Bayer1
BeiGene1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms28
Carcinoma, Non-Small-Cell Lung10
Breast Neoplasms9
Ovarian Neoplasms8
Pancreatic Neoplasms7
Neoplasm Metastasis5
Neoplasms5
Small Cell Lung Carcinoma5
Stomach Neoplasms5
Uterine Cervical Neoplasms5

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.